1 year results of first-in-man trial randomising the sirolimus eluting polylactide scaffold & everolimus eluting polylactide scaffold


P. Serruys is one of oracle’s of interventional cardiology, a pioneer in the forefront of technology and advancing clinical practice. Join us as we speak with him about the exciting second generation of BRS as he introduces 1-year results of a first-in-man trial randomising two drug-eluting scaffolds: one using sirolimus, the other with everolimus ….

The future is waiting, find out why by watching with us here!